Factorial Energy Inc. reported a net loss of $11.1 million for the nine months ended September 30, 2026, a significant improvement from the $58.1 million loss in the prior year. The company successfully completed a reverse recapitalization and PIPE financing during the period, resulting in a total stockholders' equity of $95.4 million compared to a deficit of $221.4 million at the end of 2025.
Intelligent Protection Management Corp. reported a significant revenue increase to $23.8 million for the nine months ended September 30, 2026, driven primarily by a surge in procurement revenue. Despite the top-line growth, the company incurred a net loss for the period, resulting in an accumulated deficit of $28.1 million and a decrease in total stockholders' equity to $15.4 million.
Atara Biotherapeutics reported a decrease in cash and cash equivalents to $4.1 million as of September 30, 2026, down from $8.5 million at year-end 2025. The company is currently reviewing strategic alternatives and warns that it will require substantial near-term financing to continue operations, raising concerns about its ability to fund planned operations.
Netlist reported third quarter 2026 financial results with net sales rising 149% year-over-year to $105.1 million, driven by strong AI demand and initial license fees from Samsung. The company achieved a significant turnaround in profitability, reporting net income of $85.4 million compared to a net loss in the prior year period. Cash reserves strengthened substantially to $327.7 million following a $200 million initial payment from Samsung.
Term
Q3 2026
“We are pleased to report our third consecutive quarter of significant year-over-year revenue growth and improved profitability led by both product sales and the recognition of license revenue under our Samsung agreement. Year-over-year product revenue growth was driven by strong demand from customers in AI and data center applications.”
C.K. Hong, Chief Executive Officer
“Gross margins improved and was driven by our focus on higher margin opportunities. During the quarter, we substantially strengthened our balance sheet with the initial proceeds from our Samsung agreement and generated operating cash flow of $245 million.”
BTC Development Corp. reported a net income of $5.57 million for the nine months ended September 30, 2026, primarily driven by $6.89 million in interest earned on marketable securities held in its Trust Account. As a shell company, it has not yet generated operating revenue and is currently focused on identifying a target for a business combination.
Reed's, Inc. reported Q3 2026 financial results, highlighting a gross margin expansion to 25% and a 15% reduction in SG&A expenses. Despite a slight decline in net sales to $6.5 million, the company improved its net loss to $3.2 million and strengthened its balance sheet through a loan refinancing and a subsequent $10 million private placement.
Term
Q3 2026
“The third quarter marked another step forward in our operating performance, with continued progress on gross margin and cost discipline. During the quarter, we focused on expanding retail coverage through our national broker network, adding new placements and doors, restructuring e-commerce fulfillment to reduce costs, improving trade spend efficiency, and rebalancing our cost structure.”
Neal Cohane, Reed’s interim CEO
“We continue to make quarter-over-quarter progress. In the third quarter, gross margin expanded 100 basis points sequentially to 25%, selling, general and administrative expenses decreased 24% sequentially, and net loss decreased 26% sequentially.”
TELA Bio reported a net loss of $32.8 million for the nine months ended September 30, 2026, as revenue declined slightly to $57.3 million from $59.4 million in the prior year. A significant balance sheet shift occurred as $56.3 million in debt was reclassified to current liabilities, contributing to a total stockholders' deficit of $24.6 million.
Precipio reported record quarterly revenue of $7.3 million for Q3 2026, driven by growth in both its pathology and product segments. The company achieved positive Adjusted EBITDA of $0.4 million and generated $0.6 million in cash flow from operations, ending the period with a cash balance of $3.5 million.
Term
Q3 2026
“In the third quarter we continued to strengthen our financial position, delivering record revenue while maintaining positive Adjusted EBITDA and generating cash from operations.”
Ilan Danieli, CEO of Precipio
“Our pathology business continues to provide a strong operational and financial foundation for growth, while also serving as the clinical development and validation platform for our proprietary diagnostic products.”
Energy Transition Special Opportunities reported a net income of $1,080,025 for the quarter ended September 30, 2026, primarily driven by $1,383,203 in interest earned on investments held in the Trust Account. The company completed its initial public offering in May 2026, resulting in $152,761,728 held in trust and 15,000,000 Class A ordinary shares subject to possible redemption.
BrightView reported fiscal year 2026 results with total revenue of $2.71 billion, driven by 6% growth in Maintenance Services. The company introduced fiscal 2027 guidance expecting Land Maintenance revenue growth of 3-4% and Adjusted EBITDA between $335 million and $355 million. Management highlighted three consecutive quarters of Land Maintenance growth despite macroeconomic softness in the Development Services segment.
Term
FY2026
“We closed fiscal 2026 with our third consecutive quarter of Land Maintenance revenue growth. The underlying growth rate accelerated each quarter, reaching 3.3% in the fourth quarter, as improved customer retention and continued investment in our salesforce supported momentum in this highly recurring and predictable segment.”
Dale Asplund, BrightView President and Chief Executive Officer
RideNow Group reported third quarter 2026 revenue of $244.3 million, a 13.1% decrease year-over-year, driven by lower unit volumes and the implementation of a new transparent pricing model. The company reported a net loss of $13.9 million but successfully refinanced its senior secured term loan facility with a new $220 million loan maturing in 2031.
Term
Q3 2026
“The contraction we saw in the third quarter was primarily driven by our proactive, company-wide rollout of the 'RideNow Clear Price' strategy, designed to fully comply with FTC pricing guidelines. While the August rollout impacted our retail volume against non-compliant competitors during the quarter, we believe it is the right move to build long-term customer trust and position us as the dealership group of choice.”
Michael Quartieri, Chairman, Chief Executive Officer and President
“Ultimately, the structural changes and cost reductions we are implementing, coupled with accretive acquisitions, set us up very well to capture substantial operating leverage when the broader powersports cycle rebounds.”
Michael Quartieri, Chairman, Chief Executive Officer and President
CitroTech Inc. reported a net loss of $12.39 million for the nine months ended September 30, 2026, an improvement from the $30.74 million loss in the prior year period. Total assets decreased significantly from $14.18 million at year-end 2025 to $8.55 million, primarily driven by a reduction in cash reserves used to fund operations.
First Community Corp reported a significant increase in net income to $21.1 million for the first nine months of 2026, up from $14.4 million in 2025, driven by higher interest income on loans. Total assets grew to $2.36 billion following an acquisition that added $49.7 million in common stock consideration and increased goodwill to $29.4 million.
For the nine months ended September 30, 2026, New Mountain Guardian IV BDC reported total investment income of $149.2 million and net investment income of $80.5 million. The company experienced a net decrease in members' capital resulting from operations of $49.8 million, primarily driven by $29.0 million in unrealized depreciation on investments. Total assets stood at $2.19 billion with a net asset value per unit of $9.73.
Silicon Laboratories reported a return to profitability in the third quarter of 2026 with net income of $8.9 million, compared to a net loss of $9.9 million in the prior year period. However, for the nine months ended October 3, 2026, the company remains in a net loss position of $17.6 million as revenues grew to $692.6 million from $576.6 million year-over-year.
Satellogic reported record third-quarter revenue of $16.0 million, a 342% increase year-over-year, and its second consecutive quarter of positive Adjusted EBITDA. The company highlighted significant commercial momentum in its Space Systems segment, including a post-quarter agreement to sell three in-orbit satellites for approximately $37 million. Operational milestones included the October launch of Merlin.01 and new Mark VI satellites equipped with inter-satellite links to advance its Persistent Global Intelligence strategy.
Term
Q3 2026
“We delivered an excellent third quarter, with record revenue and our second consecutive quarter of positive Adjusted EBITDA. Revenue grew 342% year-over-year to $16.0 million, following $15.9 million in the second quarter, as we continued to execute across both Data & Analytics and Space Systems.”
Vroom, Inc. reported a significant increase in cash and cash equivalents to $33.0 million as of September 30, 2026, compared to $10.4 million at the end of 2025. The company has emerged from a Prepackaged Chapter 11 Case and completed its Ecommerce Wind-Down, shifting focus to its UACC and CarStory businesses under a Long-Term Strategic Plan.
BrightView Holdings, Inc. faces risks from macroeconomic volatility, including inflation, potential recession, and supply chain disruptions affecting raw material costs like fuel and fertilizer. The company notes that economic downturns may lead customers to reduce spending on landscape services or perform maintenance in-house.
The 21Shares XRP ETF reported a net asset value of $159.7 million as of September 30, 2026, down from $247.7 million at year-end 2025. The Trust experienced a net decrease in net assets resulting from operations of $37.4 million for the nine months ended September 30, 2026, primarily driven by unrealized depreciation on its XRP holdings and cash redemptions.
GrowGeneration reported Q3 2026 financial results, achieving positive GAAP net income of $0.2 million and expanding gross margins to 32.4%. The company also announced a 2026 Restructuring Plan involving the closure of 4-5 underperforming retail locations and workforce reductions to focus on its proprietary-brand business. Full-year 2026 revenue guidance was narrowed to a range of $163 million to $165 million.
Term
Q3 2026
“Our third-quarter results reflect the continued progress of GrowGeneration's transformation into a national commercial cultivation supply and proprietary-brand platform. We delivered $44.8 million in revenue, expanded gross margin to 32.4%, and generated $2.3 million in Adjusted EBITDA.”
Darren Lampert, GrowGen’s Co-Founder and Chief Executive Officer
“We are also continuing to take meaningful actions to improve our cost structure, including a strategic restructuring plan initiated in the fourth quarter. Store and other operating expenses declined approximately 12% year-over-year, and we are moving forward with four to five store closures in the fourth quarter, along with additional restructuring initiatives designed to further reduce fixed costs and improve operating efficiency.”
Darren Lampert, GrowGen’s Co-Founder and Chief Executive Officer
Alto Neuroscience reported financial results for the third quarter ended September 30, 2026, highlighting a cash position of $319.8 million following a $100 million financing. The company confirmed its clinical pipeline remains on track, with topline data for its PACE-1 trial in treatment-resistant depression expected in the second half of 2027.
“During the third quarter, we continued to advance our clinical programs and strengthened our financial position ahead of a milestone-rich 2027. PACE-1 remains on track, and our recent financing has enabled us to expand the ALTO-207 Phase 3 development plans to include both monotherapy and adjunctive trials, aimed at supporting a broad label in TRD.”
Amit Etkin, M.D., Ph.D., founder and chief executive officer
Context Therapeutics Inc. is a clinical-stage biopharmaceutical company focusing on the development of CTIM-76 and CT-202, while winding down its CT-95 Phase 1 clinical trial. As of November 6, 2026, the company had 91,879,177 shares of common stock outstanding and is classified as a smaller reporting company and emerging growth company.
Bluerock Homes Trust reported a net loss of $8.48 million for the third quarter of 2026, with total revenues increasing to $19.20 million compared to $16.61 million in the prior year period. The company's total assets stood at $1.17 billion as of September 30, 2026, while it continued to experience net losses attributable to common stockholders of $3.14 million for the quarter.
Resideo Technologies reported Q3 2026 financial results, its first quarter following the spin-off of its ADI Global Distribution business. The company achieved 3% revenue growth to $727 million and used a $900 million dividend from the ADI separation plus cash on hand to repay $1.1 billion in gross debt.
Term
Q3 2026
“Resideo delivered top and bottom line third quarter results that were near the high end of our outlook ranges in our first quarter following the separation of ADI, underscoring our team’s continued strong execution. We achieved 3% revenue growth year-over-year across all sales channels and 6% growth year-over-year excluding OEM Security, driven by customer demand for our differentiated, non-discretionary products.”
Tom Surran, Resideo's President and CEO
“We remain focused on creating value for our customers with our differentiated products and services. That includes new AI-powered capabilities on our next-generation FORTIQ software platform, which delivers actionable intelligence that enhances customer productivity and optimizes the end-user’s experience.”
Kopin Corporation reported Q3 2026 financial results with revenue growing 52% year-over-year to $18.2 million. The company narrowed its operating loss to $0.5 million and highlighted a significant $18.6 million U.S. Army IBAS award for its MicroLED technology.
For the nine months ended September 30, 2026, the REIT reported a net loss of $5.1 million on total revenues of $43.0 million, compared to a net loss of $68,000 on $23.6 million in revenue for the same period in 2025. Total assets grew significantly to $866.4 million from $514.4 million at year-end 2025, driven by increased investments in real estate and real estate-related securities.
For the nine months ended September 30, 2026, EQT Exeter Real Estate Income Trust reported total revenues of $31.0 million and a net loss of $1.5 million. Total assets increased to $557.8 million from $541.3 million at year-end 2025, while the company continued to issue multiple classes of common stock to fund its real estate investment activities.
Revvity, Inc. reported total revenue of $728.9 million for the third quarter of 2026, a 4% increase compared to the same period in 2025. Net income for the quarter rose to $62.3 million, up from $46.7 million year-over-year, while the company continued to execute its share repurchase program, reducing outstanding common stock to approximately 111.6 million shares.
Achieve Life Sciences significantly strengthened its liquidity position, ending September 30, 2026, with $201.5 million in cash and marketable securities compared to $36.4 million at the end of 2025. The company is focused on its NDA resubmission for cytisinicline following a CRL and is currently involved in arbitration with its supplier, Sopharma.
Velo3D, Inc. reported a significant increase in total assets to $252.3 million as of September 30, 2026, driven by a rise in cash and cash equivalents to $75.7 million and a substantial increase in other assets. The company continues to focus on scaling its additive manufacturing solutions, particularly in the defense and aerospace markets, while managing its liquidity and debt obligations.